273 related articles for article (PubMed ID: 19200841)
1. Novel prophylactic and therapeutic vaccine against tuberculosis.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Inoue Y; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Vaccine; 2009 May; 27(25-26):3267-70. PubMed ID: 19200841
[TBL] [Abstract][Full Text] [Related]
2. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
3. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
Okada M; Kita Y
Kekkaku; 2010 Jun; 85(6):531-8. PubMed ID: 20662249
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Fukamizu R; Tsunai Y; Inoue R; Nakatani H; Namie Y; Yamada J; Takao K; Asai R; Asaki R; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Sakatani M
Vaccine; 2007 Apr; 25(16):2990-3. PubMed ID: 17280753
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
Yoshida S; Tanaka T; Kita Y; Kuwayama S; Kanamaru N; Muraki Y; Hashimoto S; Inoue Y; Sakatani M; Kobayashi E; Kaneda Y; Okada M
Vaccine; 2006 Feb; 24(8):1191-204. PubMed ID: 16216394
[TBL] [Abstract][Full Text] [Related]
6. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
Kita Y; Tanaka T; Yoshida S; Ohara N; Kaneda Y; Kuwayama S; Muraki Y; Kanamaru N; Hashimoto S; Takai H; Okada C; Fukunaga Y; Sakaguchi Y; Furukawa I; Yamada K; Inoue Y; Takemoto Y; Naito M; Yamada T; Matsumoto M; McMurray DN; Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Skeiky Y; Reed S; Sakatani M; Okada M
Vaccine; 2005 Mar; 23(17-18):2132-5. PubMed ID: 15755583
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Inoue Y; Matsumoto M; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Hum Vaccin; 2011; 7 Suppl():60-7. PubMed ID: 21546794
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
9. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
11. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
Kita Y; Okada M; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Takamori Y; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Hum Vaccin; 2011; 7 Suppl():108-14. PubMed ID: 21263229
[TBL] [Abstract][Full Text] [Related]
12. [The development of novel vaccines against tuberculosis].
Okada M
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):356-68. PubMed ID: 18974619
[TBL] [Abstract][Full Text] [Related]
13. The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.
Okada M; Kita Y; Nakajima T; Hashimoto S; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC
Hum Vaccin Immunother; 2013 Mar; 9(3):515-25. PubMed ID: 23249543
[TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.
Kita Y; Hashimoto S; Nakajima T; Nakatani H; Nishimatsu S; Nishida Y; Kanamaru N; Kaneda Y; Takamori Y; McMurray D; Tan EV; Cang ML; Saunderson P; Dela Cruz EC; Okada M
Hum Vaccin Immunother; 2013 Mar; 9(3):526-33. PubMed ID: 23249609
[TBL] [Abstract][Full Text] [Related]
15. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin.
Liang Y; Wu X; Zhang J; Li N; Yu Q; Yang Y; Bai X; Liu C; Shi Y; Liu Q; Zhang P; Li Z
Vaccine; 2008 Aug; 26(35):4536-40. PubMed ID: 18602439
[TBL] [Abstract][Full Text] [Related]
16. Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.
Okada M; Kita Y; Hashimoto S; Nakatani H; Nishimastu S; Kioka Y; Takami Y
Hum Vaccin Immunother; 2017 Feb; 13(2):298-305. PubMed ID: 27960629
[TBL] [Abstract][Full Text] [Related]
17. A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Inoue Y; Nagasawa T; Kaneda Y; Yoshida S; Matsumoto M; Paul S; Tan EV; Cruz ECD; N McMurray D; Sakatani M
Procedia Vaccinol; 2010; 2(1):34-39. PubMed ID: 32288910
[TBL] [Abstract][Full Text] [Related]
18. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
19. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
20. The immunogenicity and protective efficacy of Mtb8.4/hIL-12 chimeric gene vaccine.
Li H; Li R; Zhong S; Ren H; Zou Y; Chen X; Shi X; Wang M; Long H; Luo Y
Vaccine; 2006 Feb; 24(9):1315-23. PubMed ID: 16219397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
